相关实验视频
Updated: Apr 30, 2026

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
2.9K
结合治疗早产婴儿的动脉管:叙事综述
Eyad Bitar1, Aimann Surak2, Kumar Kumaran2
1Queen's University, Kingston, ON, Canada.
Journal of neonatal-perinatal medicine
|May 8, 2025
概括
在早产婴儿中管理专利动脉通道 (PDA) 是有争议的. 本综述研究了使用乙氨基和NSAIDs的组合疗法,以潜在地提高PDA关闭率和安全性.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 儿童心脏病学 儿童心脏病学
背景情况:
- 在早产婴儿的专利导管动脉 (PDA) 管理缺乏共识的治疗策略.
- 目前的PDA关闭代理显示了可变的成功率.
- 联合治疗,抑制前列腺素合成,可以提高疗效.
研究的目的:
- 对早产婴儿PDA的联合药理疗法的疗效和安全性进行审查.
- 综合有关新型PDA治疗方法的现有证据.
主要方法:
- 对现有文献进行系统审查.
- 对评估PDA组合疗法 (乙氨基和NSAIDs) 的研究进行分析.
主要成果:
- 关于组合治疗的有效性和安全性的研究有限.
- 需要进一步的研究来建立最佳的协议.
结论:
- 组合药理疗法为早产新生儿的PDA闭合提供了一个潜在的策略.
- 关于有效性和安全性的证据需要进一步调查.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
817
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817
Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598

